Gate Bioscience
Gate Bioscience is a preclinical biotechnology company founded in 2021 and headquartered in Brisbane, California, creating a new class of small-molecule medicines called Molecular Gates. Molecular Gates selectively eliminate disease-causing extracellular proteins at their origin inside the cell by b
Gate Bioscience is an API provider whose private shares are listed on 1 secondary market: EquityZen.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.
Work with this as data
Every listing here is available over the APIs.io API and to AI agents over MCP. Secondary Market is not yet its own endpoint on the v1 API. Reach it through catalog search and the tag graph, or the MCP server.
MCP server
One button, every client — Claude, Cursor, VS Code and the rest.
https://apis.io/mcp
Tools for secondary market
3 MCP tools reach this
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.resolveTurn a domain, URL or GitHub org into the provider it belongs to.find_cohortsEvery scored population of providers in the catalog.
Call it yourself
curl for this page
curl "https://apis.io/api/v1/search?q=gate-bioscience&limit=10"curl "https://apis.io/api/v1/tags/gate-bioscience"Discovery needs no key. Ratings and market analysis are Pro.